ScaiVision: our software platform

At the core of our company is Scailyte’s best-in-class analytical platform ScaiVision™. It unravels hidden secrets of complex single-cell multiomics data to extract composite biomarkers associated with different cell populations. Using a convolutional neural network, ScaiVision automatically learns molecular patterns associated with relevant clinical outcomes. These signatures can then be applied to classify new samples.

What biomarkers are you looking for?

We discover clinically-relevant biomarkers with single-cell analytics and AI

Disease diagnosis​

Disease diagnosis

Identify novel biomarkers for an early disease diagnosis

Patient stratification​

Patient stratification

Identify patients with higher chance to respond to treatment

Mode of Action​

Mode of Action

Understand the effect on patient’s immune response

Patient monitoring​

Patient monitoring

Identify prognostic and predictive biomarkers

Single-cell multi-omics data analysis for Companion Diagnostics (CDx)

Precision biomarkers & companion diagnostics
Companion diagnostics (CDx) are tests or assays that are essential for the safe and effective use of a corresponding therapeutic product. Precision oncology approaches support selecting the right treatment for the right patients, based on CDx tests, increasing the therapeutic benefit for patients, chances of a positive outcome and reducing overall healthcare costs.

ScaiVision® performs best-in-class at sample class prediction

Helping you speed up your therapy development and increase your success rate